|Description||CDK2, a member of the eukaryotic S/T protein kinase family, catalyzes the phosphoryl transfer of ATP γ-phosphate to serine or threonine hydroxyl (denoted as S0/T0) in a protein substrate. Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase.|
|Synonyms||CDK2; CDK 2; CDK-2|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
SHP099 is a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 value 0.071 μM) that stabilizes SHP2 in an auto-inhibited conformation....
SCH-51344, a pyrazoloquinolin derivative, has been found to be a MTH1 inhibitor that could be significant in anticancer studies through restraining Ras-induced ...
Boc-MLF is a selective antagonist of formyl peptide receptor 1 (FPR1) that reduces superoxide production induced by fMLF with an EC50 of 0.63 μM.
FR295389 free base
FR295389 free base is a new cephalosporin. It shows effective in vitro antibacterial activity against metallo-beta-lactamase (MBL)-producers.
R 59-022 is a diacylglycerol (DAG) kinase inhibitor (IC50 = 2.8 μM) without affecting phosphodiesterase or phosphatidylinositol kinase, and potentiates the acti...
PF-1355 is a selective, mechanism-based inhibitor of myeloperoxidase (MPO) (IC50 = 1.5 μM in LPS-stimulated human whole blood) with excellent selectivity for MP...
SPP 86 is a potent and cell-permeable RET inhibitor (IC50 = 8 nM). It also inhibits EphA1, FGFR1, Flt4, Lck and Yes. SPP 86 suppresses the proliferation of HCT ...
Benfluorex hydrochloride is a known hypolipidaemic agent with possible glucose-lowering effects. Several clinical studies have shown a reduction in triglyceride...